15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.3B | $255M | 88.1% | 19.6% | $436M | — | $702M |
| 2024 | $1.3B | $262M | 89.0% | 20.3% | $297M | — | $482M |
| 2023 | $1.3B | $201M | 88.3% | 16.6% | $337M | — | $745M |
| 2022 | $1.3B | $184M | 88.7% | 16.5% | $271M | — | $620M |
| 2021 | $1.3B | $310M | 89.9% | 26.9% | $393M | — | $1.2B |
| 2020 | $1.2B | $231M | 87.4% | 18.8% | $278M | — | $1.1B |
| 2019 | $1.2B | $255M | 87.0% | 20.7% | $231M | — | $797M |
| 2018 | $1.1B | $42M | 87.9% | 17.4% | $279M | — | $918M |
| 2017 | — | $206M | — | — | $278M | — | $634M |
| 2016 | — | $186M | — | — | $259M | — | $520M |
| 2015 | — | $181M | — | — | $152M | — | $532M |
| 2014 | — | $206M | — | — | $286M | — | $568M |
| 2013 | — | $189M | — | — | $250M | — | $454M |
| 2012 | — | $264M | — | — | $223M | — | $493M |
| 2011 | — | $309M | — | — | $356M | — | $552M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $396M | $95M | 88.7% | 28.5% | $83M | — | $594M |
| Dec '25 | $347M | $53M | 87.5% | 17.9% | $50M | — | $644M |
| Sep '25 | $307M | $49M | 87.1% | 9.7% | $107M | — | $702M |
| Jun '25 | $316M | $46M | 86.1% | 15.1% | $61M | — | $699M |
| Mar '25 | $370M | $92M | 90.3% | 29.2% | $168M | — | $627M |
| Dec '24 | $357M | $68M | 88.6% | 22.4% | $100M | — | $521M |
| Sep '24 | $305M | $59M | 88.8% | 15.2% | $109M | — | $482M |
| Jun '24 | $289M | $38M | 87.7% | 12.7% | $14M | — | $742M |
| Mar '24 | $365M | $98M | 89.4% | 29.9% | $172M | — | $710M |
| Dec '23 | $316M | $67M | 89.8% | 21.0% | $2M | — | $657M |
| Sep '23 | $291M | $9M | 87.8% | -1.2% | $77M | — | $745M |
| Jun '23 | $298M | $16M | 86.1% | 5.3% | $114M | — | $765M |
| Mar '23 | $376M | $96M | 89.1% | 29.1% | $97M | — | $688M |
| Dec '22 | $335M | $79M | 89.7% | 28.1% | $49M | — | $626M |
| Sep '22 | $278M | $28M | 86.6% | 9.7% | $41M | — | $620M |
| Jul '22 | $290M | $40M | 87.6% | 15.7% | $161M | — | $859M |
| Apr '22 | $334M | $37M | 89.4% | 13.0% | $51M | — | $900M |
| Dec '21 | $352M | $80M | 90.7% | 25.8% | $17M | — | $1.1B |
| Sep '21 | $285M | $44M | 89.2% | 14.2% | $98M | — | $1.2B |
| Jun '21 | $287M | $55M | 89.0% | 19.6% | $159M | — | $1.2B |
How the market has priced DLB against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Dolby Laboratories, Inc.'s revenue has grown 3.0% per year, and net income grown 2.0% per year. These are computed facts, not advice.
As of FY2025, Dolby Laboratories, Inc. reported — of total debt against $702M of cash.
In FY2025, gross margin was 88.1%, operating margin 19.6%, and net margin 18.9%.
As of Jun '26, Dolby Laboratories, Inc. traded at a price-to-earnings ratio of about 19.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.